What is MD Labs?
Founded in 2011, MD Labs is dedicated to advancing laboratory technologies and serving physicians across the United States. The company strategically expands its service offerings by integrating new technologies, responding to physician requests, and adapting to pharmacotherapeutic trends. This agile approach enables MD Labs to deliver rapid, accurate, and cost-effective laboratory services, ultimately enhancing patient care.
How much funding has MD Labs raised?
MD Labs has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in MD Labs
PPP
Public-Private Partnership
What's next for MD Labs?
The substantial enterprise-level funding indicates MD Labs is poised for significant scaling and further technological development. This capital injection will likely fuel expansion into new markets, enhance research and development capabilities, and potentially lead to strategic acquisitions. The company's focus on physician-driven innovation suggests a future roadmap centered on deepening its value proposition to healthcare providers and improving patient outcomes through cutting-edge diagnostics.
See full MD Labs company page